Clinical Trial Update: Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients

View source ↗

Summary

This clinical trial update reports a completed study on positron emission radiomics using PSMA radioligands in newly diagnosed prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Prostate Cancer | Status: COMPLETED